Results from the NASH-FX Study Underscore the Importance of Completing the NASH-CX Clinical Trial for Patients with NASH Cirrhosis
0 Comments , in Article
On September 27, 2016, we announced the results of our NASH-FX Phase 2a exploratory clinical study on the use of GR-MD-02 in nonalcoholic steatohepatitis (NASH) patients with advanced fibrosis. While...
Read More